Concepedia

Author

Makoto Akiyama

Kyoto Prefectural University of MedicineORCID

Also Known As

M Akiyama, M. Akiyama, Makoto AKIYAMA, Makoto Akiyama, Masashi AKIYAMA

43

Publications

218

Citations

8

H-Index

23

Concepts

All Affiliations

Kyoto Prefectural University of MedicineJikei University School of Medicine
MA

About

Makoto Akiyama is an author at Kyoto Prefectural University of Medicine specializing in medicine, tumor biology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

101

2

Cell Biology

2

2

75

3

Obstetrics

2

2

70

4

Endocrinology

1

1

44

5

Pathology

1

1

26

Makoto Akiyama

×

6

Publications

172

Citations

6

H-Index

YearCitations

Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer

Hiroshi Matsushima, Taisuke Mori, Fumitake Ito,

Oncotarget

2016

44

Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer

Takuro Yamamoto, Taisuke Mori, Morio Sawada,

BMC Cancer

2015

32

Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.

H Sasaki, S Niimi, Makoto Akiyama,

PubMed

1999

31

Clear Cell Carcinoma Arising from Cesarean Section Scar Endometriosis: Case Report and Review of the Literature

Sakura Ijichi, Taisuke Mori, Izumi Suganuma,

Case Reports in Obstetrics and Gynecology

2014

26

Usefulness of Moistening Seprafilm Before Use in Laparoscopic Surgery

Izumi Kusuki, Izumi Suganuma, Fumitake Ito,

Surgical Laparoscopy Endoscopy & Percutaneous Techniques

2014

26

Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G<sub>2</sub> Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells

Makoto Akiyama, Yoshihiro Sowa, Tomoyuki Taniguchi,

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

2017

13

Page 1